Holdings (Monthly)
Guide ↗
iShares U.S. Pharmaceuticals ETF
· iShares Trust| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | JOHNSON & JOHNSON | 478160104 | Jun 2026 | 1,005,964 | $255.5M | 22.44% | EC |
| 2 | ELI LILLY AND COMPANY | 532457108 | Jun 2026 | 211,122 | $253.2M | 22.25% | EC |
| 3 | BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | 066922519 | Jun 2026 | 71,038,218 | $71.1M | 6.24% | STIV |
| 4 | MERCK & CO., INC. | 58933Y105 | Jun 2026 | 402,911 | $51.8M | 4.55% | EC |
| 5 | BRISTOL-MYERS SQUIBB COMPANY | 110122108 | Jun 2026 | 862,993 | $49.7M | 4.37% | EC |
| 6 | ROYALTY PHARMA PLC | G7709Q104 | Jun 2026 | 880,087 | $49.3M | 4.33% | EC |
| 7 | VIATRIS INC. | 92556V106 | Jun 2026 | 3,025,794 | $48.0M | 4.22% | EC |
| 8 | PFIZER INC. | 717081103 | Jun 2026 | 1,874,313 | $45.1M | 3.96% | EC |
| 9 | ZOETIS INC. | 98978V103 | Jun 2026 | 590,261 | $42.4M | 3.73% | EC |
| 10 | JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY | G50871105 | Jun 2026 | 163,023 | $39.3M | 3.45% | EC |
| 11 | ELANCO ANIMAL HEALTH INCORPORATED | 28414H103 | Jun 2026 | 1,297,692 | $31.9M | 2.81% | EC |
| 12 | AXSOME THERAPEUTICS, INC. | 05464T104 | Jun 2026 | 112,311 | $27.5M | 2.41% | EC |
| 13 | CORCEPT THERAPEUTICS INCORPORATED | 218352102 | Jun 2026 | 248,243 | $21.6M | 1.90% | EC |
| 14 | LIGAND PHARMACEUTICALS INCORPORATED | 53220K504 | Jun 2026 | 52,070 | $16.5M | 1.45% | EC |
| 15 | Definium Therapeutics Inc | 24477V105 | Jun 2026 | 336,035 | $15.8M | 1.39% | EC |
| 16 | Liquidia Corp | 53635D202 | Jun 2026 | 182,536 | $14.6M | 1.28% | EC |
| 17 | INDIVIOR PHARMACEUTICALS, INC. | 45579U109 | Jun 2026 | 316,782 | $13.0M | 1.14% | EC |
| 18 | Crinetics Pharmaceuticals Inc | 22663K107 | Jun 2026 | 273,936 | $10.3M | 0.90% | EC |
| 19 | ORGANON & CO. | 68622V106 | Jun 2026 | 683,028 | $9.2M | 0.81% | EC |
| 20 | Edgewise Therapeutics Inc | 28036F105 | Jun 2026 | 195,894 | $8.0M | 0.70% | EC |
| 21 | AMNEAL PHARMACEUTICALS, INC. | 03168L105 | Jun 2026 | 448,079 | $7.8M | 0.68% | EC |
| 22 | Enliven Therapeutics Inc | 29337E102 | Jun 2026 | 141,435 | $7.2M | 0.63% | EC |
| 23 | SUPERNUS PHARMACEUTICALS, INC. | 868459108 | Jun 2026 | 150,961 | $7.0M | 0.62% | EC |
| 24 | Tarsus Pharmaceuticals Inc | 87650L103 | Jun 2026 | 102,786 | $6.5M | 0.57% | EC |
| 25 | Veradermics Inc | 922967104 | Jun 2026 | 52,065 | $6.4M | 0.56% | EC |
| 26 | Alumis Inc | 022307102 | Jun 2026 | 221,521 | $6.2M | 0.55% | EC |
| 27 | NEKTAR THERAPEUTICS | 640268306 | Jun 2026 | 87,878 | $6.1M | 0.54% | EC |
| 28 | PRESTIGE CONSUMER HEALTHCARE INC. | 74112D101 | Jun 2026 | 122,984 | $5.8M | 0.51% | EC |
| 29 | Trevi Therapeutics Inc | 89532M101 | Jun 2026 | 306,511 | $5.7M | 0.50% | EC |
| 30 | OCULAR THERAPEUTIX, INC. | 67576A100 | Jun 2026 | 455,448 | $4.5M | 0.39% | EC |
| 31 | INNOVIVA, INC. | 45781M101 | Jun 2026 | 182,305 | $4.1M | 0.36% | EC |
| 32 | Amylyx Pharmaceuticals Inc | 03237H101 | Jun 2026 | 219,612 | $3.9M | 0.35% | EC |
| 33 | ANI PHARMACEUTICALS, INC. | 00182C103 | Jun 2026 | 47,404 | $3.9M | 0.34% | EC |
| 34 | MBX Biosciences Inc | 55287L101 | Jun 2026 | 69,247 | $3.8M | 0.34% | EC |
| 35 | HARMONY BIOSCIENCES HOLDINGS, INC. | 413197104 | Jun 2026 | 103,804 | $3.8M | 0.33% | EC |
| 36 | PERRIGO COMPANY PUBLIC LIMITED COMPANY | G97822103 | Jun 2026 | 359,528 | $3.7M | 0.33% | EC |
| 37 | HARROW, INC. | 415858109 | Jun 2026 | 86,214 | $3.7M | 0.32% | EC |
| 38 | NUVATION BIO INC. | 67080N101 | Jun 2026 | 633,601 | $3.6M | 0.32% | EC |
| 39 | XERIS BIOPHARMA HOLDINGS, INC. | 98422E103 | Jun 2026 | 448,501 | $3.6M | 0.31% | EC |
| 40 | Rapport Therapeutics Inc | 75383L102 | Jun 2026 | 74,520 | $3.1M | 0.27% | EC |
| 41 | Collegium Pharmaceutical, Inc. | 19459J104 | Jun 2026 | 84,237 | $3.0M | 0.27% | EC |
| 42 | EYEPOINT, INC. | 30233G209 | Jun 2026 | 204,659 | $2.9M | 0.26% | EC |
| 43 | AtaiBeckley Inc | 04650F101 | Jun 2026 | 506,160 | $2.7M | 0.23% | EC |
| 44 | PACIRA BIOSCIENCES, INC. | 695127100 | Jun 2026 | 102,108 | $2.6M | 0.23% | EC |
| 45 | WAVE Life Sciences Ltd | Y95308105 | Jun 2026 | 394,231 | $2.3M | 0.20% | EC |
| 46 | Maze Therapeutics Inc | 578784100 | Jun 2026 | 73,160 | $2.2M | 0.19% | EC |
| 47 | LB Pharmaceuticals Inc | 50180M108 | Jun 2026 | 63,173 | $2.1M | 0.18% | EC |
| 48 | BIOAGE Labs Inc | 09077V100 | Jun 2026 | 82,938 | $2.0M | 0.18% | EC |
| 49 | Septerna Inc | 81734D104 | Jun 2026 | 59,605 | $2.0M | 0.18% | EC |
| 50 | AMPHASTAR PHARMACEUTICALS, INC. | 03209R103 | Jun 2026 | 88,493 | $1.8M | 0.16% | EC |
| 51 | OMEROS CORPORATION | 682143102 | Jun 2026 | 187,604 | $1.8M | 0.16% | EC |
| 52 | PHIBRO ANIMAL HEALTH CORPORATION | 71742Q106 | Jun 2026 | 54,917 | $1.7M | 0.15% | EC |
| 53 | THERAVANCE BIOPHARMA, INC. | G8807B106 | Jun 2026 | 98,073 | $1.7M | 0.15% | EC |
| 54 | CORMEDIX INC. | 21900C308 | Jun 2026 | 190,159 | $1.5M | 0.13% | EC |
| 55 | PHATHOM PHARMACEUTICALS, INC. | 71722W107 | Jun 2026 | 133,024 | $1.4M | 0.13% | EC |
| 56 | Arvinas Inc | 04335A105 | Jun 2026 | 168,155 | $1.4M | 0.12% | EC |
| 57 | Evolus Inc | 30052C107 | Jun 2026 | 171,630 | $1.2M | 0.10% | EC |
| 58 | BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares | 066922477 | Jun 2026 | 808,355 | $808K | 0.07% | STIV |
| 59 | XAV HEALTH CARE SEP26 | 1XAVU26 | Jun 2026 | 4 | $27K | 0.00% | DE |